Effects of an isopropanolic extract of Cimicifuga racemosa on urinary crosslinks and other parameters of bone quality in an ovariectomized rat model of osteoporosis

Journal of Bone and Mineral Metabolism

Volumn 21, Issue 6, 2003, Pages 370-376

  Nißlein, Thomas ^a   Freudenstein, Johannes ^a  

^a Schaper & Brummer GmbH & Co KG   (Germany)

Author keywords

Animal model; Cimicifuga racemosa; Osteoporosis; Phytotherapy; Urinary crosslinks

Indexed keywords

CIMICIFUGA RACEMOSA EXTRACT; DEOXYPYRIDINOLINE; PYRIDINOLINE; RALOXIFENE; TRITERPENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE MINERAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CROSS LINKING; DIETARY INTAKE; DRUG EFFECT; FEMALE; FRACTURE; MEASUREMENT; MORPHOMETRICS; NONHUMAN; OSTEOLYSIS; OSTEOPOROSIS; OVARIECTOMY; PRIORITY JOURNAL; RAT; URINALYSIS; VOLUMETRY;

2-PROPANOL; AMINO ACIDS; ANIMALS; BONE AND BONES; BONE DENSITY; CIMICIFUGA; FEMALE; OSTEOPOROSIS; OVARIECTOMY; PHYTOTHERAPY; PLANT EXTRACTS; RALOXIFENE; RATS;

EID: 0345732157     PISSN: 09148779     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00774-003-0431-9     Document Type: Article

References (39)

1. Patel MS, Rubin LA, Cole (2000) Genetic determinants of osteoporosis. In: Henderson JE, Goltzman D (eds). The Osteoporosis Primer. Cambridge University Press, Cambridge, pp 131-146
2. Matkovic V, Landoll JD (2000) Non-genetic determinants of peak bone mass. In: Henderson JE, Goltzman D (eds) The Osteoporosis Primer. Cambridge University Press, Cambridge, pp 147-169
3. Eastell R (1998) Treatment of postmenopausal osteoporosis. N Engl J Med 338:736-746
4. Papapoulos SE (1998) Pharmacological management of osteoporosis. Aging (Milano) 10:263-268
5. Sato M, Grese TA, Dodge JA, Bryant HU, Turner CH (1999) Emerging therapies for the prevention or treatment of postmenopausal osteoporosis. J Med Chem 42:1-24
6. Cauley JA, Seeley DG, Ensrud K, Ettinger B, Black D, Cummings SR (1995) Estrogen replacement therapy and fractures in older women: study of osteoporotic fractures. Ann Intern Med 122:9-16
7. Cetinkaya MB, Kokcu A, Yanik FF, Basoglu T, Malatyalioglu E, Alper T (2002) Comparison of the effects of transdermal estrogen, oral estrogen, and oral estrogen-progestogen therapy on bone mineral density in postmenopausal women. J Bone Miner Metab 20:44-48
8. Grady D, et al. HERS Research Group (2002) Cardiovascular disease outcomes during 6.8 years of hormone therapy. JAMA 288:1-13
9. Petitti DB (2002) Hormone replacement therapy for prevention-more evidence, more pessimism. JAMA 288:1-7
10. Colditz GA (1997) Hormone replacement therapy increases the risk of breast cancer. Ann NY Acad Sci 833:129-136
11. Liske E, Hanggi W, Henneicke-Von Zepelin HH, Boblitz N, Wustenberg P, Rahlfs VW (2002) Physiological investigation of a unique extract of black cohosh (Cimicifugae racemosae rhizoma): a 6-month clinical study demonstrates no systemic estrogenic effect. J Women's Health Gender-Based Med 11:163-174
12. Li JX, Kadota S, Li HY, Miyahara T, Wu YW, Seto H, Namba T (1996/97) Effects of Cimicifugae rhizoma on serum calcium and phosphate levels in low calcium dietary rats and on bone mineral density in ovariectomized rats. Phytomedicine 3:379-385
13. Cranney A, Welch V, Tugwell P, Wells G, Adachi JD, McGowan J, Shea B (1999) Responsiveness of endpoints in osteoporosis clinical trials: an update. J Rheumatol 26:222-228
14. Ohishi T, Takahashi M, Kushida K, Yamazaki K, Hoshino H, Kitazawa A, Inoue T (1998) Urinary collagen crosslinks reflect further bone loss of femoral neck in osteoporotic patients undergoing vitamin D therapy. Endocr Res 24:259-267
15. Edelson GW, Kleerekoper M (1998) The use of bone markers in osteoporosis. J Clin Ligand Assay 21:96-101
16. Fraser WD (1998) The collagen crosslinks pyridinoline and deoxypyridinoline: a review of their biochemistry, physiology, measurement, and clinical applications. J Clin Ligand Assay 21:102-110
17. Garnero P, Delmas PD (1998) Biochemical markers of bone turnover - Applications for osteoporosis. Endocrinol Metab Clin N Am 27:303-323
18. Miller PD, Zapalowski C, Kulak CAM, Bilezikian JP (1999) Bone densitometry: the best way to detect osteoporosis and to monitor therapy. J Clin Endocrinol Metab 84:1867-1871
19. Black D, Duncan A, Robins SP (1988) Quantitative analysis of the pyridinium crosslinks of collagen in urine using ion-paired reversed-phase high-performance liquid chromatography. Anal Biochem 169:197-203
20. Black D, Farquharson C, Robins SP (1989) Excretion of pyridinium crosslinks of collagen in ovariectomized rats as urinary markers for increased bone resorption. Calcif Tissue Int 44:343-347
21. Kalu DN, Liu CC, Salerno E, Hollis BW, Echon R, Ray M (1991) Skeletal response of ovariectomized rats to low and high doses of 17β-estradiol. Bone Miner 14:175-187
22. Arjmandi BH, Alekel L, Hollis BW, Amin D, Stacewicz-Sapuntzakis M, Guo P, Kukreja SC (1996) Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J Nutr 126:161-167
23. Mattila PT, Knuuttila MLE, Svanberg MJ (1998) Dietary xylitol supplementation prevents osteoporotic changes in streptozotocin-diabetic rats. Metabolism 47:578-583
24. Hoshino K, Hanyu T, Arai K, Takahashi HE (2001) Mineral density and histomorphometric assessment of bone changes in the proximal tibia early after induction of type II collagen-induced arthritis in growing and mature rats. J Bone Miner Metab 19:76-83
25. Helminen HJ, Hyttinen MM, Lammi MJ, Arokoski JP, Lapvetelainen T, Jurvelin J, Kiviranta I, Tammi MI (2000) Regular joint loading in youth assists in the establishment and strengthening of the collagen network of articular cartilage and contributes to the prevention of osteoarthrosis later in life: a hypothesis. J Bone Miner Metab 18:245-257
26. Reeve J, Mitchell A, Tellez M, Hulme P, Green JR, Wardley-Smith B, Mitchell R (2001) Treatment with parathyroid peptides and estrogen replacement for severe postmenopausal vertebral osteoporosis: prediction of long-term responses in spine and femur. J Bone Miner Metab 19:102-114
27. Frolik CA, Bryant HU, Black EC, Magee DE, Chandrasekhar S (1996) Time-dependent changes in biochemical bone markers and serum cholesterol in ovariectomized rats: effects of raloxifene HCl, tamoxifen, estrogen, and alendronate. Bone (NY) 18:621-627
28. Braidman I, Baris C, Wood L, Selby P, Adams J, Freemont A, Hoyland J (2000) Preliminary evidence for impaired estrogen receptor-α protein expression in osteoblasts and osteocytes from men with idiopathic osteoporosis. Bone (NY) 26:423-427
29. Braidman IP, Baris C, Selby PL, Adams JE, Freemont AJ, Hoyland JA (2000) Preliminary report of impaired oestrogen receptor-α expression in bone, but no involvement of androgen receptor, in male idiopathic osteoporosis. J Pathol 192:90-96
30. Braidman IP, Hainey L, Batra G, Selby PL, Saunders PTK, Hoyland JA (2001) Localization of estrogen receptor β protein expression in adult human bone. J Bone Miner Res 16:214-220
31. Kruse SO, Löhning A, Pauli GF, Winterhoff H, Nahrstedt A (1999) Fukiic and piscidic acid esters from the rizome of Cimicifuga racemosa and the in vitro estrogenic activity of fukinolic acid. Planta Med 65:763-764
32. Einer-Jensen N, Zhao J, Andersen KP, Kristoffersen K (1996) Cimicifuga and Melbrosia lack oestrogenic effects in mice and rats. Maturitas 25:149-153
33. Bodinet C, Freudenstein J (2002) Influence of Cimicifuga racemosa on the proliferation of estrogen receptor positive human breast cancer cells. Breast Cancer Res Treat 76:1-10
34. Freudenstein J, Dasenbrock C, Nißlein T (2002) Lack of promotion of estrogen-dependent mammary gland tumors in vivo by an isopropanolic Cimicifuga racemosa extract. Can Res 62:3448-3452
35. Lieberman S (1998) A review of the effectiveness of Cimicifufa racemosa (black cohosh) for the symptoms of menopause. J Womens Health 7:525-529
36. Pepping J (1999) Black cohosh: Cimicifuga racemosa. Am J Health Syst Pharm 56:1400-1402
37. Ammann P, Rizzoli R, Slosman D, Bonjour J-P (1992) Sequential and precise in vivo measurement of bone mineral density in rats using dual-energy x-ray absorptiometry. J Bone Miner Res 7:311-316
38. Grynpas MD, Chachra D, Lundon K (2000) Bone quality in animal models of osteoporosis. Drug Dev Res 49:146-158
39. Nishizawa Y, Nakamura T, Ohata H, Kushida K, Gorai I, Shiraki M, Fukunaga M, Hosoi T, Miki T, Nakatsuka K, Miura M (2001) Guidelines on the use of biochemical markers of bone turnover in osteoporosis. J Bone Miner Metab 19:338-344